Actinium Pharmaceuticals, Inc. SEC filings ATNM

Actinium Pharmaceuticals, Inc. has 511 filings in SEC EDGAR's recent list, going back to Feb 5, 2007. Its latest annual report, Form ARS, was filed on Oct 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 15, 2026 (officer or director change, regulation fd disclosure). The company's fiscal year ends on December 31.

Actinium Pharmaceuticals, Inc. SEC filings
Form Description Filed Period
ARS Annual report to shareholders Oct 15, 2026 Dec 31, 2025
DEF 14A Proxy statement Oct 15, 2026 Nov 25, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Oct 15, 2026 Oct 14, 2026
S-8 Employee stock plan registration Oct 9, 2026 —
8-K Current report
Listing notice, Regulation FD disclosure
Aug 14, 2026 Aug 12, 2026
10-Q Quarterly report Aug 7, 2026 Jun 30, 2026
8-K Current report
Other events
Jun 18, 2026 Jun 18, 2026
8-K Current report
Listing notice, Regulation FD disclosure
May 29, 2026 May 27, 2026
10-Q Quarterly report May 8, 2026 Mar 31, 2026
10-K Annual report Mar 30, 2026 Dec 31, 2025
8-K/A Amended current report
Shareholder vote results
Mar 26, 2026 Nov 26, 2025
8-K Current report
Officer or director change
Feb 13, 2026 Feb 11, 2026
8-K Current report
Officer or director change, Shareholder vote results
Nov 26, 2025 Nov 26, 2025
10-Q Quarterly report Nov 14, 2025 Sep 30, 2025
ARS Annual report to shareholders Nov 5, 2025 Dec 31, 2024
DEF 14A Proxy statement Nov 5, 2025 Nov 26, 2025
10-Q Quarterly report Aug 8, 2025 Jun 30, 2025
10-Q Quarterly report May 9, 2025 Mar 31, 2025
8-K Current report
Auditor change
May 9, 2025 May 8, 2025
10-K Annual report Mar 31, 2025 Dec 31, 2024
8-K Current report
Officer or director change, Shareholder vote results
Nov 27, 2024 Nov 27, 2024
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
ARS Annual report to shareholders Nov 6, 2024 Dec 31, 2023
8-K Current report
Officer or director change, Other events
Nov 5, 2024 Nov 1, 2024
DEF 14A Proxy statement Nov 5, 2024 Nov 27, 2024
10-Q Quarterly report Aug 5, 2024 Jun 30, 2024
8-K Current report
Regulation FD disclosure
Aug 5, 2024 Aug 5, 2024
10-Q Quarterly report Apr 26, 2024 Mar 31, 2024
S-8 Employee stock plan registration Mar 29, 2024 —
10-K Annual report Mar 29, 2024 Dec 31, 2023
EFFECT Filing Feb 5, 2024 —
S-3/A Pre-effective amendment no. 1 to form s-3 Feb 2, 2024 —
CORRESP Letter to the SEC Feb 2, 2024 —
8-K Current report
Officer or director change, Shareholder vote results
Dec 1, 2023 Nov 30, 2023
ARS Annual report to shareholders Nov 9, 2023 Dec 31, 2022
DEF 14A Proxy statement Nov 9, 2023 Nov 30, 2023
10-Q Quarterly report Nov 2, 2023 Sep 30, 2023
UPLOAD Letter from the SEC Aug 17, 2023 —
10-Q Quarterly report Aug 14, 2023 Jun 30, 2023
S-3 Shelf registration Aug 11, 2023 —
10-Q Quarterly report May 15, 2023 Mar 31, 2023
10-K Annual report Mar 31, 2023 Dec 31, 2022
8-K Current report
Regulation FD disclosure
Mar 10, 2023 Mar 10, 2023
8-K Current report
Regulation FD disclosure
Feb 21, 2023 Feb 18, 2023
8-K Current report
Officer or director change, Shareholder vote results
Dec 30, 2022 Dec 30, 2022
DEFA14A Additional proxy material Dec 9, 2022 —
8-K Current report
Other events
Dec 9, 2022 Dec 8, 2022
DEF 14A Proxy statement Nov 21, 2022 Dec 8, 2022
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
8-K Current report
Regulation FD disclosure
Oct 31, 2022 Oct 31, 2022
S-8 Employee stock plan registration Aug 19, 2022 —
10-Q Quarterly report Aug 12, 2022 Jun 30, 2022
8-K Current report
Material agreement
Jun 29, 2022 Jun 28, 2022
424B3 Prospectus Jun 28, 2022 —
10-Q Quarterly report May 13, 2022 Mar 31, 2022
8-K Current report
Material agreement
Apr 13, 2022 Apr 7, 2022
10-K Annual report Mar 25, 2022 Dec 31, 2021
10-Q Quarterly report Nov 12, 2021 Sep 30, 2021
8-K Current report
Officer or director change, Shareholder vote results
Nov 9, 2021 Nov 9, 2021
DEFA14A Additional proxy material Nov 5, 2021 —
DEF 14A Proxy statement Oct 18, 2021 Nov 9, 2021
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 23, 2021 Sep 22, 2021
10-Q Quarterly report Jul 30, 2021 Jun 30, 2021
10-Q Quarterly report May 14, 2021 Mar 31, 2021
10-K Annual report Mar 31, 2021 Dec 31, 2020
8-K Current report
Officer or director change, Shareholder vote results
Nov 20, 2020 Nov 18, 2020
DEFA14A Additional proxy material Oct 28, 2020 —
8-K Current report
Regulation FD disclosure
Oct 28, 2020 Oct 28, 2020
10-Q Quarterly report Oct 23, 2020 Sep 30, 2020
DEFA14A Additional proxy material Oct 7, 2020 —
DEF 14A Proxy statement Oct 7, 2020 Nov 18, 2020
EFFECT Filing Aug 14, 2020 —
10-Q Quarterly report Aug 14, 2020 Jun 30, 2020
8-K Current report
Bylaw or fiscal year change, Other events
Aug 14, 2020 Aug 10, 2020
CORRESP Letter to the SEC Aug 14, 2020 —
UPLOAD Letter from the SEC Aug 13, 2020 —
S-3 Shelf registration Aug 7, 2020 —
8-K Current report
Other events
Aug 5, 2020 Aug 5, 2020
8-K Current report
Other events
Jul 24, 2020 Jul 22, 2020
10-K/A Amended annual report Jul 13, 2020 Dec 31, 2019
10-Q Quarterly report Jun 29, 2020 Mar 31, 2020
8-K Current report
Other events
Jun 19, 2020 Jun 19, 2020
8-K Current report
Material agreement, Other events
Jun 18, 2020 Jun 16, 2020
424B5 Prospectus supplement Jun 18, 2020 —
8-K Current report
Other events
Jun 16, 2020 Jun 16, 2020
424B5 Prospectus supplement Jun 16, 2020 —
8-K Current report
Bylaw or fiscal year change
Jun 16, 2020 Jun 16, 2020
10-K/A Amended annual report Jun 16, 2020 Dec 31, 2019
8-K Current report
Other events
May 15, 2020 May 15, 2020
10-K Annual report May 8, 2020 Dec 31, 2019
8-K Current report
Bylaw or fiscal year change
May 5, 2020 May 5, 2020
8-K Current report
Listing notice
May 5, 2020 Apr 29, 2020
8-K Current report
Material agreement
Apr 24, 2020 Apr 21, 2020
424B5 Prospectus supplement Apr 22, 2020 —
424B5 Prospectus supplement Apr 21, 2020 —
8-K Current report
Other events
Mar 27, 2020 Mar 20, 2020
8-K Current report
Shareholder vote results
Dec 19, 2019 Dec 18, 2019
8-K Current report
Other events
Dec 3, 2019 Dec 2, 2019
DEF 14A Proxy statement Nov 25, 2019 Dec 18, 2019
8-K Current report
Officer or director change, Other events
Nov 25, 2019 Nov 25, 2019
PRE 14A Preliminary proxy statement Nov 15, 2019 Nov 15, 2019
10-Q Quarterly report Nov 12, 2019 Sep 30, 2019
10-Q Quarterly report Aug 9, 2019 Jun 30, 2019
8-K Current report
Other events
Jun 7, 2019 Jun 7, 2019
10-Q Quarterly report May 10, 2019 Mar 31, 2019
S-8 Employee stock plan registration May 10, 2019 —
8-K Current report
Material agreement, Regulation FD disclosure
Apr 18, 2019 Apr 18, 2019
424B5 Prospectus supplement Apr 18, 2019 —
424B5 Prospectus supplement Apr 17, 2019 —
10-K Annual report Mar 15, 2019 Dec 31, 2018
8-K Current report
Material agreement, Bylaw or fiscal year change
Mar 12, 2019 Mar 6, 2019
424B5 Prospectus supplement Dec 28, 2018 —
8-K Current report
Material agreement
Dec 28, 2018 Dec 28, 2018
8-K Current report
Officer or director change
Dec 26, 2018 Dec 21, 2018
8-K Current report
Shareholder vote results
Dec 21, 2018 Dec 18, 2018
DEF 14A Proxy statement Nov 16, 2018 Dec 18, 2018
10-Q Quarterly report Nov 9, 2018 Sep 30, 2018
PRE 14A Preliminary proxy statement Oct 30, 2018 Nov 8, 2018
8-K Current report
Material agreement
Oct 18, 2018 Oct 18, 2018
424B5 Prospectus supplement Oct 18, 2018 —
8-K Current report
Auditor change
Aug 15, 2018 Aug 9, 2018
10-Q Quarterly report Aug 9, 2018 Jun 30, 2018
10-Q Quarterly report May 10, 2018 Mar 31, 2018
8-K Current report
Officer or director change
May 1, 2018 Apr 27, 2018
S-8 Employee stock plan registration Mar 16, 2018 —
10-K Annual report Mar 16, 2018 Dec 31, 2017
8-K Current report
Other events
Mar 9, 2018 Mar 6, 2018
424B5 Prospectus supplement Feb 26, 2018 —
8-K Current report
Bylaw or fiscal year change, Other events
Feb 26, 2018 Feb 26, 2018
424B5 Prospectus supplement Feb 15, 2018 —
8-K Current report
Material agreement
Feb 15, 2018 Feb 15, 2018
8-K Current report
Material agreement, Officer or director change
Feb 8, 2018 Feb 6, 2018
424B5 Prospectus supplement Feb 1, 2018 —
8-K Current report
Regulation FD disclosure
Jan 25, 2018 Jan 23, 2018
8-K Current report
Material agreement, Officer or director change
Jan 8, 2018 Jan 2, 2018
8-K Current report
Shareholder vote results
Dec 21, 2017 Dec 20, 2017
DEF 14A Proxy statement Nov 14, 2017 Dec 20, 2017
10-Q Quarterly report Nov 3, 2017 Sep 30, 2017
PRE 14A Preliminary proxy statement Oct 30, 2017 Dec 20, 2017
424B3 Prospectus Oct 24, 2017 —
424B3 Prospectus Oct 24, 2017 —
EFFECT Filing Oct 12, 2017 —
CORRESP Letter to the SEC Oct 10, 2017 —
UPLOAD Letter from the SEC Oct 5, 2017 —
CORRESP Letter to the SEC Oct 3, 2017 —
S-3/A Amendment no. 1 to form s-3 Oct 3, 2017 —
CORRESP Letter to the SEC Oct 3, 2017 —
UPLOAD Letter from the SEC Sep 26, 2017 —
10-Q Quarterly report Aug 4, 2017 Jun 30, 2017
424B5 Prospectus supplement Jul 31, 2017 —
8-K Current report
Material agreement, Regulation FD disclosure
Jul 28, 2017 Jul 27, 2017
424B5 Prospectus supplement Jul 27, 2017 —
8-K Current report
Material agreement
Jul 3, 2017 Jul 3, 2017
424B5 Prospectus supplement Jul 3, 2017 —
8-K Current report
Material agreement, Officer or director change
Jun 16, 2017 Jun 15, 2017
8-K Current report
Officer or director change
Jun 9, 2017 Jun 5, 2017
8-K Current report
Material agreement
Jun 8, 2017 Jun 6, 2017
8-K/A Amended current report
Officer or director change
May 26, 2017 May 12, 2017
8-K Current report
Officer or director change
May 16, 2017 May 12, 2017
10-Q Quarterly report May 15, 2017 Mar 31, 2017
8-K Current report
Material agreement, Officer or director change
May 11, 2017 May 5, 2017
NT 10-Q Notification of late filing May 10, 2017 Mar 31, 2017
UPLOAD Letter from the SEC Apr 5, 2017 —
8-K Current report
Officer or director change, Other events
Mar 28, 2017 Mar 27, 2017
S-3 Shelf registration Mar 16, 2017 —
S-8 Employee stock plan registration Mar 16, 2017 —
10-K Annual report Mar 16, 2017 Dec 31, 2016
8-K Current report
Shareholder vote results
Dec 22, 2016 Dec 21, 2016
8-K Current report
Material agreement
Dec 14, 2016 Dec 13, 2016
DEFA14A Additional proxy material Dec 14, 2016 —
DEFA14A Additional proxy material Dec 8, 2016 —
DEFA14A Additional proxy material Nov 30, 2016 —
DEF 14A Proxy statement Nov 18, 2016 Dec 21, 2016
10-Q Quarterly report Oct 28, 2016 Sep 30, 2016
424B5 Prospectus supplement Sep 29, 2016 —
8-K Current report
Material agreement, Regulation FD disclosure
Sep 29, 2016 Sep 28, 2016
424B5 Prospectus supplement Sep 28, 2016 —
8-K Current report
Regulation FD disclosure
Aug 4, 2016 Aug 4, 2016
10-Q Quarterly report Jul 29, 2016 Jun 30, 2016
10-Q Quarterly report May 10, 2016 Mar 31, 2016
10-K Annual report Mar 11, 2016 Dec 31, 2015
8-K Current report
Material agreement, Shareholder vote results
Dec 24, 2015 Dec 21, 2015
8-K Current report
Material agreement
Dec 16, 2015 Dec 15, 2015
8-K Current report
Bylaw or fiscal year change, Other events
Nov 27, 2015 Nov 20, 2015
DEFA14A Additional proxy material Nov 27, 2015 —
8-K Current report
Other events
Nov 18, 2015 Nov 17, 2015
DEF 14A Proxy statement Nov 12, 2015 Oct 16, 2015
10-Q Quarterly report Oct 30, 2015 Sep 30, 2015
10-Q Quarterly report Aug 7, 2015 Jun 30, 2015
8-K Current report
Results of operations, Regulation FD disclosure
Aug 3, 2015 Jul 29, 2015
8-K Current report
Material agreement
Jun 5, 2015 Jun 4, 2015
424B5 Prospectus supplement Jun 5, 2015 —
10-Q Quarterly report May 8, 2015 Mar 31, 2015
10-K Annual report Mar 16, 2015 Dec 31, 2014
8-K Current report
Bylaw or fiscal year change
Mar 4, 2015 Feb 26, 2015
424B5 Prospectus supplement Feb 6, 2015 —
8-K Current report
Material agreement, Other events
Feb 6, 2015 Feb 6, 2015
8-K Current report
Other events
Feb 5, 2015 Feb 5, 2015
424B5 Prospectus supplement Feb 5, 2015 —
8-K Current report
Shareholder vote results
Dec 24, 2014 Dec 22, 2014

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ATNM (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New York, NY
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1388320
Former names
Cactus Ventures, Inc. (until Mar 29, 2013)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.